{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:01:44Z","timestamp":1789542104884,"version":"build-2803163510"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T00:00:00Z","timestamp":1702425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["CERIC_20217127"],"award-info":[{"award-number":["CERIC_20217127"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020931","name":"CERIC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020931","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ejps.2023.106673","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T18:15:49Z","timestamp":1702577749000},"page":"106673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2"],"prefix":"10.1016","volume":"193","author":[{"given":"Fabiola","family":"Guareschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Del Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cant\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Brandolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Sambri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nicoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pescina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Buttini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Bettini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-1456","authenticated-orcid":false,"given":"Fabio","family":"Sonvico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106673_bib0001","first-page":"4","article-title":"Growth and maintenance of Vero cell lines","volume":"4","author":"Ammerman","year":"2008","journal-title":"CurrProtoc Microbiol"},{"issue":"4","key":"10.1016\/j.ejps.2023.106673_bib0002","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00524-13","article-title":"Severe Acute Respiratory Syndrome Coronavirus Nonstructural Proteins 3, 4, and 6 Induce Double-Membrane Vesicles","volume":"4","author":"Angelini","year":"2013","journal-title":"MBio"},{"issue":"2","key":"10.1016\/j.ejps.2023.106673_bib0003","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1006\/bbrc.1993.2487","article-title":"Evidence for a Polarized Efflux System in Caco-2 Cells Capable of Modulating Cyclosporine A Transport","volume":"197","author":"Augustijns","year":"1993","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"1","key":"10.1016\/j.ejps.2023.106673_bib0004","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.ph.57.030195.003223","article-title":"Mucin Biophysics","volume":"57","author":"Bansil","year":"1995","journal-title":"Annu. Rev. Physiol."},{"issue":"5","key":"10.1016\/j.ejps.2023.106673_bib0005","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.1021\/acsomega.9b00603","article-title":"Solubility Studies of Cyclosporine Using Ionic Liquids","volume":"4","author":"Berton","year":"2019","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.ejps.2023.106673_bib0006","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0194599820982633","article-title":"COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission","volume":"164","author":"Bleier","year":"2020","journal-title":"Otolaryngol. Neck Surg."},{"key":"10.1016\/j.ejps.2023.106673_bib0007","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1515\/CCLM.2007.199","article-title":"IFCC Position Paper: Report of the IFCC Taskforce on Ethics: Introduction and framework","volume":"45","author":"Burnett","year":"2007","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.ejps.2023.106673_bib0008","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/03639045.2012.707210","article-title":"Development of in vitro models to demonstrate the ability of PecSys\u00ae, an in situ nasal gelling technology, to reduce nasal run-off and drip","volume":"39","author":"Castile","year":"2013","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2023.106673_bib0009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s43440-023-00463-7","article-title":"Nasal sprays for treating COVID-19: a scientific note","volume":"75","author":"Chavda","year":"2023","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.ejps.2023.106673_bib0010","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1016\/j.drudis.2021.07.021","article-title":"Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management","volume":"26","author":"Chavda","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"10223","key":"10.1016\/j.ejps.2023.106673_bib0011","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ejps.2023.106673_bib0012","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.1c00366","article-title":"Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs","volume":"18","author":"Clementino","year":"2021","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2023.106673_bib0013","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/mp900191s","article-title":"Vitamin TPGS P-Glycoprotein Inhibition Mechanism: Influence on Conformational Flexibility, Intracellular ATP Levels, and Role of Time and Site of Access","volume":"7","author":"Collnot","year":"2010","journal-title":"Mol. Pharm"},{"issue":"11","key":"10.1016\/j.ejps.2023.106673_bib0014","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1099\/vir.0.034983-0","article-title":"Cyclosporin A inhibits the replication of diverse coronaviruses","volume":"92","author":"De Wilde","year":"2011","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejps.2023.106673_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110439","article-title":"Novel O\/W nanoemulsions for nasal administration: Structural hints in the selection of performing vehicles with enhanced mucopenetration","volume":"183","author":"Di Cola","year":"2019","journal-title":"Colloids Surfaces B Biointerfaces"},{"issue":"12","key":"10.1016\/j.ejps.2023.106673_bib0016","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1055\/s-2007-1008498","article-title":"Diagnostic value of nasal secretions, current state: normal values","volume":"62","author":"Eichner","year":"1983","journal-title":"Laryngol. Rhinol. Otol."},{"issue":"24","key":"10.1016\/j.ejps.2023.106673_bib0017","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1021\/jm00076a002","article-title":"Solvent-Dependent Conformation and Hydrogen-Bonding Capacity of Cyclosporin A: Evidence from Partition Coefficients and Molecular Dynamics Simulations","volume":"36","author":"El Tayar","year":"1993","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106673_bib0018","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jconrel.2022.07.019","article-title":"Cyclosporine-loaded micelles for ocular delivery: Investigating the penetration mechanisms","volume":"349","author":"Ghezzi","year":"2022","journal-title":"J. Cont. Release"},{"key":"10.1016\/j.ejps.2023.106673_bib0019","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2021.02.031","article-title":"Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions","volume":"332","author":"Ghezzi","year":"2021","journal-title":"J. Control. Release."},{"issue":"4","key":"10.1016\/j.ejps.2023.106673_bib0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"Coronaviridae Study Grp, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.ejps.2023.106673_bib0021","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.carbpol.2018.08.073","article-title":"Cyclosporine-loaded cross-linked inserts of sodium hyaluronan and hydroxypropyl-\u03b2-cyclodextrin for ocular administration","volume":"201","author":"Grimaudo","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.ejps.2023.106673_bib0022","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/acs.molpharmaceut.7b00939","article-title":"Poloxamer 407\/TPGS Mixed Micelles as Promising Carriers for Cyclosporine Ocular Delivery","volume":"15","author":"Grimaudo","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2023.106673_bib0023","first-page":"35","article-title":"Solubilization and Pharmacokinetic Behaviors of Sodium Cholate\/Lecithin-Mixed Micelles Containing Cyclosporine A. Drug Deliv","volume":"12","author":"Guo","year":"2005","journal-title":"J. Deliv. Target. Ther. Agents."},{"issue":"3","key":"10.1016\/j.ejps.2023.106673_bib0024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS- CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"issue":"8","key":"10.1016\/j.ejps.2023.106673_bib0025","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11095-011-0417-6","article-title":"Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast","volume":"28","author":"Kundoor","year":"2011","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.ejps.2023.106673_bib0026","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue damage from neutrophil-induced oxidative stress in COVID-19 Mireille","volume":"20","author":"Laforge","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.ejps.2023.106673_bib0027","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci"},{"issue":"2","key":"10.1016\/j.ejps.2023.106673_bib0028","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.addr.2008.09.012","article-title":"Micro- and macrorheology of mucus","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejps.2023.106673_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":"Cyclosporine A delivery to the eye: A pharmaceutical challenge","volume":"56","author":"Lallemand","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejps.2023.106673_bib0030","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejps.2005.05.003","article-title":"A water-soluble prodrug of cyclosporine A for ocular application: A stability study","volume":"26","author":"Lallemand","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106673_bib0031","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpb.2017.03.006","article-title":"Cyclosporine A delivery to the eye: A comprehensive review of academic and industrial efforts","volume":"117","author":"Lallemand","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.ejps.2023.106673_bib0032","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/js960503w","article-title":"Diffusion of Drugs in Native and Purified Gastrointestinal Mucus","volume":"86","author":"Larhed","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106673_bib0033","first-page":"12250","article-title":"On the Calculation of TCID50 for Quantitation of Virus Infectivity","author":"Lei","year":"2020","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ejps.2023.106673_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100056","article-title":"Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19","volume":"7","author":"Liu","year":"2020","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.ejps.2023.106673_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ICO.0b013e3182a7f3bf","article-title":"Self-Assembling Colloidal System for the Ocular Administration of Cyclosporine A","volume":"33","author":"Luschmann","year":"2014","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ejps.2023.106673_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1004166","article-title":"Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus","volume":"10","author":"Lundin","year":"2014","journal-title":"PLOS Pathog"},{"issue":"4","key":"10.1016\/j.ejps.2023.106673_bib0037","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1248\/cpb.57.388","article-title":"Gellan gum based microparticles of metoclopromide hydrochloride for intranasal delivery: Development and evaluation","volume":"57","author":"Mahajan","year":"2009","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejps.2023.106673_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104620","article-title":"Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication","volume":"173","author":"Ma-Lauer","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejps.2023.106673_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2022.828078","article-title":"Emerging Roles of Cyclophilin A in Regulating Viral Cloaking","volume":"13","author":"Mamatis","year":"2022","journal-title":"Front. Microbiol."},{"issue":"10229","key":"10.1016\/j.ejps.2023.106673_bib0040","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejps.2023.106673_bib0041","first-page":"487\u2014490","article-title":"Cyclosporine pharmacokinetics in pancreas transplant Recipients","volume":"20","author":"Munda","year":"1988","journal-title":"Transplant. Proc"},{"issue":"2","key":"10.1016\/j.ejps.2023.106673_bib0042","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2012.09.051","article-title":"Enhancement of corneal permeation of riboflavin-5\u2032-phosphate through vitamin E TPGS: A promising approach in corneal trans-epithelial cross linking treatment","volume":"440","author":"Ostacolo","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejps.2023.106673_bib0043","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01658-17","article-title":"Expression and Cleavage of Middle East Respiratory Syndrome Coronavirus nsp3-4 Polyprotein Induce the Formation of Double-Membrane Vesicles That Mimic Those Associated with Coronaviral RNA Replication","volume":"8","author":"Oudshoorn","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.ejps.2023.106673_bib0044","series-title":"Water-soluble tocopherol derivatives inhibit SARS-CoV-2 RNA-dependent RNA polymerase, (Preprint)","author":"Pacl","year":"2021"},{"issue":"2","key":"10.1016\/j.ejps.2023.106673_bib0046","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: An overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J. Pharmacol."},{"issue":"16","key":"10.1016\/j.ejps.2023.106673_bib0047","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1016\/j.bmcl.2013.05.101","article-title":"Cyclophilin inhibitors as antiviral agents","volume":"23","author":"Peel","year":"2013","journal-title":"Bioorganic Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejps.2023.106673_bib0048","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejps.2013.04.012","article-title":"How do polymeric micelles cross epithelial barriers?","volume":"50","author":"Pepi\u0107","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106673_bib0049","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pharmaceutics11090476","article-title":"Ex Vivo Conjunctival Retention and Transconjunctival Transport of Poorly Soluble Drugs Using Polymeric Micelles","volume":"11","author":"Pescina","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106673_bib0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/pharmaceutics13060855","article-title":"Preliminary Investigation on Simvastatin-Loaded Polymeric Micelles in View of the Treatment of the Back of the Eye","volume":"13","author":"Pescina","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2023.106673_bib0051","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1371\/journal.ppat.1002331","article-title":"The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors","volume":"7","author":"Pfefferle","year":"2011","journal-title":"PLoS Pathog"},{"issue":"19","key":"10.1016\/j.ejps.2023.106673_bib0052","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1021\/acs.langmuir.7b00701","article-title":"Structural and Spectroscopic Characterization of TPGS Micelles: Disruptive Role of Cyclodextrins and Kinetic Pathways","volume":"33","author":"Puig-Rigall","year":"2017","journal-title":"Langmuir"},{"issue":"3","key":"10.1016\/j.ejps.2023.106673_bib0053","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.ejps.2023.106673_bib0054","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0167-5699(92)90111-J","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"13","author":"Schreiber","year":"1992","journal-title":"Immunol. Today."},{"key":"10.1016\/j.ejps.2023.106673_bib0055","article-title":"Formulation, optimization and evaluation of vitamin E TPGS emulsified dorzolamide solid lipid nanoparticles","volume":"68","author":"Shahab","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejps.2023.106673_bib0056","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/17425247.2023.2263363","article-title":"Nasal delivery as a strategy for the prevention and treatment of COVID-19","volume":"20","author":"Sonvico","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"issue":"22","key":"10.1016\/j.ejps.2023.106673_bib0057","doi-asserted-by":"crossref","first-page":"11875","DOI":"10.1073\/pnas.2006874117","article-title":"The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission","volume":"117","author":"Stadnytskyi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ejps.2023.106673_bib0058","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12551-016-0218-6","article-title":"Cyclosporine A delivery to the eye: Dynamic light scattering: a practical guide and applications in biomedical sciences","volume":"8","author":"Stetefeld","year":"2016","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ejps.2023.106673_bib0059","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"17","key":"10.1016\/j.ejps.2023.106673_bib0060","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1021\/jm500223x","article-title":"From Chemical Tools to Clinical Medicines: Nonimmunosuppressive Cyclophilin Inhibitors Derived from the Cyclosporin and Sanglifehrin Scaffold","volume":"57","author":"Sweeney","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2023.106673_bib0061","article-title":"SARS-CoV-2 accelerated clearance using a novel nitric oxide nasal spray (NONS) treatment: A randomized trial","volume":"3","author":"Tandon","year":"2022","journal-title":"Lancet Reg. Heal. - Southeast Asia"},{"issue":"46","key":"10.1016\/j.ejps.2023.106673_bib0062","doi-asserted-by":"crossref","first-page":"19268","DOI":"10.1073\/pnas.0905998106","article-title":"Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier","volume":"106","author":"Tang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"50","key":"10.1016\/j.ejps.2023.106673_bib0063","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1002\/ange.200803526","article-title":"Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that \u201cSlip\u201d through the Human Mucus Barrier","volume":"120","author":"Wang","year":"2008","journal-title":"Angew. Chemie."},{"issue":"7809","key":"10.1016\/j.ejps.2023.106673_bib0064","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ejps.2023.106673_bib0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.ogx.0000688032.41075.a8","article-title":"Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study","volume":"75","author":"Wu","year":"2020","journal-title":"Obstet. Gynecol. Surv."},{"issue":"9","key":"10.1016\/j.ejps.2023.106673_bib0066","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo","volume":"9","author":"Xu","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ejps.2023.106673_bib0067","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1080\/10717544.2018.1458923","article-title":"Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies","volume":"25","author":"Yu","year":"2018","journal-title":"Drug Deliv"},{"issue":"12","key":"10.1016\/j.ejps.2023.106673_bib0068","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients","volume":"382","author":"Zou","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723003019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723003019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:09:02Z","timestamp":1760530142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723003019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":67,"alternative-id":["S0928098723003019"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106673","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106673"}}